# Comparing the outcomes

> Comparing repair outcomes | Sports Peptides — Sports Peptides compares the actual outcomes for BPC-157, TB-500, GHK-Cu and KPV, from animal blood flow to human skin and safety studies.

The compounds share a sporting reputation. The experiments have different participants, treatments and finish lines.

## A comparison by measured outcome

The idea of a league table of the ‘best’ repair peptide irritates me. The experiments supply no common event to rank. Here is the comparison that the sources can actually support.

| Compound discussed | Tested material and subjects | Measured outcome |
|---|---|---|
| BPC-157 | BPC-157 in vascular cells, chick tissue and rats with restricted muscle blood supply | [Increased vessel density and faster blood-flow recovery](https://pubmed.ncbi.nlm.nih.gov/27847966/) |
| TB-500 | Full-length thymosin beta-4 in male Wistar rats after stroke | [Neurological improvement at some amounts; no significant benefit at the highest](https://pubmed.ncbi.nlm.nih.gov/25060418/) |
| GHK-Cu | Topical GHK-Cu in small human skin studies | [Changes in skin laxity, fine lines, wrinkle depth and density](https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/) |
| KPV | KPV in intestinal cell cultures and mouse colitis models | [Reduced inflammatory signaling and disease severity](https://pubmed.ncbi.nlm.nih.gov/18061177/) |

## The participants in the human studies

The [BPC-157 intravenous pilot](https://pubmed.ncbi.nlm.nih.gov/40131143/) observed two healthy adults and safety biomarkers. The [thymosin beta-4 study](https://pubmed.ncbi.nlm.nih.gov/20536472/) used a placebo comparison in forty healthy volunteers. Both make more limited claims than a trial of injured athletes would make, and the latter tested full-length protein rather than TB-500.

For GHK, the [hair-growth trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/) involved forty-five men over six months and tested a combination with 5-aminolevulinic acid. Its endpoint was hair count. The skin studies summarized in the [topical review](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/) concern dermatologic outcomes and delivery through skin.

I value those human data for the particular questions they answer. Contact-sport recovery is still waiting for its own convincing evidence.

## Three kinds of amplification

**A larger amount.** The [rat stroke result](https://pubmed.ncbi.nlm.nih.gov/25060418/) resists a simple progression toward greater benefit. It gives no basis for a human escalation scheme.

**A broader outcome.** Skin appearance, blood flow and inflammatory cytokines each describe something measurable. Extending any one of them to athletic performance changes the question.

**A simpler treatment.** The [KPV combination particles](https://pubmed.ncbi.nlm.nih.gov/39211778/) and the [GHK hair mixture](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/) included more than the peptide name that usually heads a discussion. Their results describe those combinations.

I’d choose the exact, sometimes awkward result over an inflated sporting conclusion. A finding can be valuable while leaving other recovery questions open.

## Competition and safety

The [sports-medicine review](https://pubmed.ncbi.nlm.nih.gov/41966639/) found scarce rigorous human safety evidence for unapproved repair peptides despite favorable animal results. Uncertain long-term harms and unreliable product identity are material gaps.

BPC-157 is prohibited at all times, and TB-500 and thymosin beta-4 are also prohibited under the relevant sport categories. GHK-Cu and KPV need attention to wider rules for non-approved substances. The current anti-doping authority supplies the eligibility answer.

I see two unresolved questions here: how an injured person fares, and which rules apply to a particular sporting situation. Neither the table nor a personal recovery story can settle them. The [FAQ](/faq) takes the common questions individually.

---

An independent sports-medicine literature brief on repair peptides—evidence and prohibited-list context, never clinical or evasion advice.